Retatrutide should not be used without professional screening, especially for people with diabetes, digestive disorders, gallbladder issues, thyroid concerns, or a history of pancreatitis
It is also helpful for patients who have already lost weight but are unsure whether their plan is protecting muscle, supporting energy, improving metabolic markers, and preparing them for maintenance rather than short-term results
If appropriate, your provider will develop a personalized treatment plan based on your medical history, clinical needs, and treatment goals
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan